Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
30 employees
Laronde pioneers an innovative RNA-based platform for modulating human biology.
HQ
Founded
2017
Laronde, founded by Flagship Pioneering, is revolutionizing the field of biotechnology with its innovative RNA-based platform designed to modulate human biology. The company's core mission is to generate tomorrow's medicines today by leveraging the language of life. Laronde focuses on developing programmable medicines using its proprietary translatable circular RNA technology, aiming to create life-changing impacts for people globally. Their market focus includes addressing unmet medical needs through cutting-edge bioplatforms and product candidates powered by evolution and AI.
Notable affiliated individuals include the visionary team at Flagship Pioneering, who have a history of nurturing groundbreaking biotech companies. Laronde has garnered significant attention and investment from leading biotech investors due to its pioneering approach. Key achievements include the development of a first-in-category translatable circular RNA technology, positioning Laronde as a leader in the field of programmable medicines. The company's overall impact lies in its potential to transform therapeutic approaches and deliver novel treatments for various diseases, thereby advancing global healthcare.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
RNA Therapeutics
Technology
AI, Biotech
Tags
Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Laronde founded?
Laronde was founded in 2017.
Where is Laronde's headquarters located?
Laronde's headquarters is located in Cambridge, MA, US.
When was Laronde's last funding round?
Laronde's most recent funding round was for $440M (USD) in August 2021.
How many employees does Laronde have?
Laronde has 30 employees as of Feb 4, 2024.
How much has Laronde raised to-date?
As of July 05, 2023, Laronde has raised a total of $490M (USD) since Aug 30, 2021.
Add Comparison
Total Raised to Date
$490M
USD
Last Update Aug 30, 2021
Last Deal Details
$440M
USD
Aug 30, 2021
Series B
Current Employees
30
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts